IQVIA Biotech Thought Leadership

  1. A Strategic Approach To CAGT Study Conduct And Operations 11/3/2024

    Cell and gene therapy clinical trials require adaptive regulatory and operational strategies to address complex challenges, streamline patient engagement, and support successful development and delivery.

  2. Quantifying Potential: Leveraging Data To Showcase Biotech Value 1/14/2026

    Biotechs must use data-driven insights to prove asset potential. Real-world evidence and predictive analytics validate differentiation, forecast market opportunity, and build investor confidence.

  3. Big Futures For Emerging Biopharma: Navigating Biotech Hurdles 1/14/2026

    Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.

  4. De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital 9/3/2025

    For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.

  5. The Role Of FDA Initiatives In Early-Phase Oncology Trials 5/15/2025

    Project FrontRunner represents a paradigm shift in oncology drug development, championing earlier-line studies to bring novel treatments to patients sooner.

  6. Accelerate Drug Development With Master Protocols 5/15/2025

    Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.

  7. Elevating Patient Centricity In Clinical Trials 2/17/2025

    How can the integration of patient perspectives throughout the clinical trial process enhance engagement and outcomes?

  8. Crafting The Vision: Building A Strong Value Story For Biotechs 1/14/2026

    Early-stage biotechs need more than science — they need a clear vision. Learn to craft a value story that shows differentiation, market potential, and patient impact to attract investors and partners.

  9. Leading With Purpose: Meg Hooton's Global Journey in Biotech 1/14/2026

    Biotech leadership requires vision, adaptability, and purpose. Aligning values with strategy and fostering collaboration empowers teams and drives innovation in a rapidly evolving industry.

  10. Beyond The Benchmark: Innovative Trial Designs Transform Research 1/15/2026

    Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.